Ledger.Open graph →
SEC Form D · filed February 24, 2021

Ribogenics, Inc

Offering
$8.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Wei Zhang · Hong Kong, Hong KongDirectorWei Zhang · HOLLISTON, MADirectorYves Ribeill · Philadelphia, PAExecLaurent Arthaud · Philadelphia, PADirectorSerge Braun · Philadelphia, PADirectorYves Ribeill · Philadelphia, PAExecLaurent Arthaud · Philadelphia, PADirectorSerge Braun · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗